The US House of Representatives yesterday passed a bill aiming to expand the “right to try” experimental drugs, sending the bill, which is backed by President Trump, to the Senate.
The bill would allow terminally ill patients access to investigational drugs drugs that haven’t been approved by the FDA, according to a report from The Hill. Patients would be able to request drugs as long as those drugs had been through initial clinical trials and were under consideration by the FDA.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!